Pioneering the field of digital therapeutics
We strive for the ideal of medical care,
a world where all people can receive high-quality treatment without worry.
Evolving treatment with the power of technology,
we will solve the social issues surrounding healthcare and realize ideal medical care.
We develop evidence-based medical programs, “Digital Therapeutics (DTx),” for patients who suffer from conditions that conventional treatment methods with drugs or devices were not effective. We aim to deliver the new treatment to as many patients as possible.
Digital therapeutics opens the door to new intervention schemes without physical limitations (remotely at home, outside business hours). With the technology, we can realize effective personalized intervention through evidence-based personalized guidance promoting cognitive and behavioral changes.Service Concept Service List
World’s first real-world data on the hypotensive effects of digital therapeutics
CureApp, Inc. and Sawai Group Holdings Co., Ltd. enter into a development and marketing license agreement for a DTx*1 solution in the NASH field
Carlyle to Acquire a Significant Minority Stake in CureApp, a Leading Prescription Digital Therapeutics Provider in Japan